MACK logo

Merrimack Pharmaceuticals, Inc. Stock Price

NasdaqGM:MACK Community·US$223.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

MACK Share Price Performance

US$0
0.00 (0.00%)
US$0
0.00 (0.00%)
Price US$0

MACK Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and slightly overvalued.

2 Risks
1 Reward

Merrimack Pharmaceuticals, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$1.3m

Other Expenses

-US$1.3m

Earnings

Last Reported Earnings
Mar 31, 2024
Next Reporting Earnings
n/a
-0.091
0%
0%
0%
View Full Analysis

About MACK

Founded
1993
Employees
n/a
CEO
Gary Crocker
WebsiteView website
www.merrimack.com

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company in the United States. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Recent MACK News & Updates

Recent updates

No updates